Danaher Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Danaher Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2015-10-02 | 2015-07-03 | 2015-04-03 | 2014-09-26 | 2014-06-27 | 2014-03-28 | 2013-09-27 | 2013-06-28 | 2013-03-29 | 2012-12-31 | 2012-09-28 | 2012-06-29 | 2012-03-30 | 2011-12-31 | 2011-09-30 | 2011-07-01 | 2011-04-01 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||
net earnings | 2,668,800,000 | 1,265,400,000 | 569,800,000 | 1,936,700,000 | 1,256,100,000 | 579,700,000 | 1,905,700,000 | 1,308,700,000 | 691,900,000 | 630,404,000 | 548,735,000 | 600,149,000 | 612,912,000 | 570,714,000 | 523,428,000 | 648,764,000 | 429,358,000 |
noncash items: | |||||||||||||||||
depreciation | 416,100,000 | 279,700,000 | 138,500,000 | 415,000,000 | 272,600,000 | 132,200,000 | 390,400,000 | 257,000,000 | 127,500,000 | 129,319,000 | 123,672,000 | 123,790,000 | 121,019,000 | 118,583,000 | 125,449,000 | 57,185,000 | 49,443,000 |
amortization of intangible assets | |||||||||||||||||
amortization of acquisition-related inventory fair value step-up | |||||||||||||||||
stock-based compensation expense | 101,200,000 | 60,800,000 | 31,400,000 | 88,900,000 | 55,000,000 | 29,000,000 | |||||||||||
investment losses and pretax gain on sale of product line | |||||||||||||||||
impairment charges | |||||||||||||||||
change in trade accounts receivable | 49,500,000 | 44,700,000 | 125,600,000 | -97,700,000 | -158,700,000 | -5,900,000 | -5,400,000 | -28,900,000 | 105,900,000 | -214,198,000 | 141,236,000 | -104,433,000 | 97,695,000 | -139,004,000 | 18,575,000 | -78,061,000 | 63,211,000 |
change in inventories | -96,500,000 | -108,500,000 | -119,000,000 | -77,000,000 | -58,800,000 | -67,000,000 | -119,000,000 | -112,500,000 | -89,400,000 | 123,373,000 | -26,984,000 | 49,574,000 | -76,163,000 | 152,108,000 | 42,191,000 | 11,920,000 | -44,200,000 |
change in trade accounts payable | -142,600,000 | -101,800,000 | -91,300,000 | -62,900,000 | -51,000,000 | -96,800,000 | 99,700,000 | 82,000,000 | 10,100,000 | 18,517,000 | -32,876,000 | 47,833,000 | 23,526,000 | 12,949,000 | |||
change in prepaid expenses and other assets | 161,800,000 | 101,000,000 | -100,000 | 104,000,000 | 81,400,000 | 36,200,000 | 157,300,000 | 113,400,000 | 43,600,000 | -210,387,000 | 33,767,000 | -8,262,000 | 84,582,000 | -172,008,000 | 6,653,000 | 25,228,000 | 29,117,000 |
change in accrued expenses and other liabilities | -153,500,000 | -139,700,000 | -240,200,000 | -16,300,000 | -62,000,000 | -188,700,000 | -115,400,000 | -156,300,000 | -207,000,000 | 42,329,000 | 77,964,000 | 241,491,000 | -214,984,000 | -60,029,000 | -67,340,000 | 163,429,000 | -175,162,000 |
net cash from operating activities | 2,570,200,000 | 1,617,600,000 | 523,600,000 | 2,519,000,000 | 1,502,900,000 | 511,200,000 | 2,507,100,000 | 1,535,700,000 | 636,500,000 | 799,673,000 | 961,144,000 | 1,008,971,000 | 645,212,000 | ||||
cash flows from investing activities: | |||||||||||||||||
cash paid for acquisitions | -14,207,100,000 | -598,900,000 | -487,600,000 | -634,900,000 | -606,700,000 | -162,800,000 | -868,600,000 | -322,600,000 | -12,100,000 | -823,977,000 | -27,756,000 | -889,340,000 | -55,727,000 | -123,750,000 | -30,808,000 | -5,538,859,000 | -517,420,000 |
payments for additions to property, plant and equipment | -438,700,000 | -258,100,000 | -119,200,000 | -421,400,000 | -278,600,000 | -130,900,000 | -391,800,000 | -252,500,000 | -116,300,000 | -124,921,000 | -104,827,000 | -110,728,000 | -117,824,000 | -116,489,000 | -109,888,000 | -59,670,000 | -48,424,000 |
proceeds from sales of property, plant and equipment | |||||||||||||||||
payments for purchases of investments | -87,100,000 | -87,100,000 | -87,100,000 | -80,000,000 | |||||||||||||
proceeds from sales of investments | 30,700,000 | 25,000,000 | |||||||||||||||
proceeds from sale of product line | |||||||||||||||||
all other investing activities | 38,100,000 | 6,500,000 | 3,200,000 | 20,700,000 | 11,200,000 | 9,000,000 | -3,600,000 | -5,900,000 | -8,900,000 | ||||||||
total cash from investing activities | |||||||||||||||||
cash flows from financing activities: | |||||||||||||||||
proceeds from the issuance of common stock in connection with stock-based compensation | |||||||||||||||||
payment of dividends | -261,600,000 | -165,900,000 | -70,400,000 | -157,400,000 | -87,400,000 | -17,400,000 | -34,700,000 | -17,300,000 | -34,362,000 | -17,306,000 | -17,420,000 | -17,312,000 | -17,194,000 | -17,156,000 | -13,705,000 | -13,268,000 | |
net borrowings | |||||||||||||||||
net | -247,500,000 | -185,068,000 | 52,947,000 | -362,926,000 | |||||||||||||
net repayments of borrowings | -259,900,000 | -11,300,000 | -13,400,000 | -768,000,000 | -768,000,000 | -764,300,000 | |||||||||||
payments for repurchase of common stock | |||||||||||||||||
all other financing activities | -3,300,000 | -3,300,000 | -3,300,000 | ||||||||||||||
total cash from financing activities | |||||||||||||||||
effect of exchange rate changes on cash and equivalents | -81,600,000 | -44,200,000 | -66,700,000 | -112,100,000 | -4,400,000 | -9,900,000 | 2,700,000 | -14,800,000 | -8,700,000 | 2,426,000 | 8,555,000 | -13,176,000 | 4,895,000 | 3,719,000 | 65,000 | -3,999,000 | 36,589,000 |
net change in cash and equivalents | -1,172,100,000 | 336,400,000 | -494,600,000 | 910,100,000 | 205,900,000 | 231,300,000 | 316,900,000 | 646,200,000 | 472,000,000 | 137,366,000 | 423,095,000 | 74,957,000 | 506,282,000 | 52,633,000 | -67,215,000 | -1,041,976,000 | -39,421,000 |
beginning balance of cash and equivalents | 3,005,600,000 | 3,005,600,000 | 3,005,600,000 | 3,115,200,000 | 3,115,200,000 | 3,115,200,000 | 1,678,700,000 | 1,678,700,000 | 1,678,700,000 | -1,000 | 0 | 0 | 537,001,000 | 0 | 0 | 0 | 1,632,980,000 |
ending balance of cash and equivalents | 1,833,500,000 | 3,342,000,000 | 2,511,000,000 | 4,025,300,000 | 3,321,100,000 | 3,346,500,000 | 1,995,600,000 | 2,324,900,000 | 2,150,700,000 | 137,365,000 | 423,095,000 | 74,957,000 | 1,043,283,000 | 52,633,000 | -67,215,000 | -1,041,976,000 | 1,593,559,000 |
supplemental disclosures: | |||||||||||||||||
cash interest payments | 97,800,000 | 57,700,000 | 37,300,000 | 97,700,000 | 60,300,000 | 37,200,000 | 127,300,000 | 60,700,000 | 37,700,000 | 64,976,000 | 23,575,000 | 38,311,000 | 70,107,000 | 2,070,000 | 36,369,000 | ||
cash income tax payments | 325,400,000 | 225,100,000 | 101,000,000 | 380,700,000 | 238,300,000 | 68,200,000 | 351,000,000 | 182,700,000 | 57,100,000 | 77,338,000 | 94,910,000 | 53,937,000 | 205,194,000 | 69,411,000 | 93,285,000 | ||
sales | |||||||||||||||||
diluted net earnings per common share | |||||||||||||||||
pretax gain on sale of product line and investment losses | |||||||||||||||||
payments for the issuance of common stock in connection with stock-based compensation | |||||||||||||||||
less: earnings from discontinued operations, net of income taxes | 805,300,000 | 0 | 0 | 92,858,000 | |||||||||||||
net earnings from continuing operations | 1,905,700,000 | 1,308,700,000 | 691,900,000 | 630,362,000 | 548,735,000 | 600,149,000 | 520,054,000 | ||||||||||
investment (gains) losses | |||||||||||||||||
total operating cash from continuing operations | 2,507,100,000 | 1,535,700,000 | 636,500,000 | 830,835,000 | 975,411,000 | 1,044,497,000 | 651,357,000 | ||||||||||
total operating cash from discontinued operations | -31,162,000 | -14,267,000 | -35,526,000 | -6,145,000 | |||||||||||||
total investing cash from continuing operations | -14,651,800,000 | -572,000,000 | 111,000,000 | 554,700,000 | -942,123,000 | -123,492,000 | -988,767,000 | -170,718,000 | |||||||||
total investing cash from discontinued operations | -38,800,000 | 0 | 0 | -26,000 | |||||||||||||
net proceeds from | 6,148,400,000 | 3,100,000 | |||||||||||||||
trade accounts receivable | |||||||||||||||||
inventories | |||||||||||||||||
property, plant and equipment | |||||||||||||||||
goodwill | |||||||||||||||||
other intangible assets, primarily technology and customer relationships | |||||||||||||||||
deferred tax liabilities | |||||||||||||||||
other assets and liabilities | |||||||||||||||||
net assets acquired | |||||||||||||||||
less: noncash consideration | |||||||||||||||||
net cash consideration | |||||||||||||||||
proceeds from (payments for) the issuance of common stock in connection with stock-based compensation | |||||||||||||||||
diluted net earnings per common share from continuing operations | |||||||||||||||||
contract settlement expense | |||||||||||||||||
pretax loss on early extinguishment of borrowings | |||||||||||||||||
pretax gain on sale of product lines and investment (gains) losses | |||||||||||||||||
change in deferred income taxes | |||||||||||||||||
total cash from investing activities from continuing operations | |||||||||||||||||
net cash from investing activities | -14,690,600,000 | -937,600,000 | -690,700,000 | -998,200,000 | -849,100,000 | -284,700,000 | -572,000,000 | 111,000,000 | 554,700,000 | -942,067,000 | -123,492,000 | -988,767,000 | 166,726,000 | -243,508,000 | -121,388,000 | -4,917,403,000 | -564,955,000 |
proceeds from borrowings | 4,950,400,000 | ||||||||||||||||
repayments of borrowings | -2,100,000 | -1,800,000 | -1,200,000 | -404,900,000 | -403,600,000 | -1,000,000 | -966,900,000 | -310,400,000 | -500,000 | -58,065,000 | -1,221,000 | -858,000 | -1,356,000 | -7,806,000 | -1,592,552,000 | 0 | -2,021,000 |
distribution from discontinued operations | |||||||||||||||||
make-whole premiums to redeem borrowings prior to maturity | |||||||||||||||||
net cash from financing activities for continuing operations | |||||||||||||||||
cash distributions to veralto corporation | |||||||||||||||||
net cash from financing activities | 11,029,900,000 | -299,400,000 | -260,800,000 | -498,600,000 | -443,500,000 | 14,700,000 | -1,620,900,000 | -985,700,000 | -710,500,000 | 277,334,000 | -423,112,000 | 67,929,000 | -310,551,000 | -534,771,000 | -645,834,000 | 3,216,777,000 | 52,462,000 |
supplemental disclosure: | |||||||||||||||||
distribution of noncash net assets to veralto corporation | |||||||||||||||||
finished goods | |||||||||||||||||
work in process | |||||||||||||||||
raw materials | |||||||||||||||||
total | |||||||||||||||||
operating profit | |||||||||||||||||
numerator: | |||||||||||||||||
mcps dividends | |||||||||||||||||
net earnings attributable to common stockholders for basic eps | |||||||||||||||||
adjustment for mcps dividends for dilutive mcps | |||||||||||||||||
net earnings attributable to common stockholders after assumed conversions for diluted eps | |||||||||||||||||
denominator: | |||||||||||||||||
weighted-average common shares outstanding used in basic eps | |||||||||||||||||
incremental common shares from: | |||||||||||||||||
assumed exercise of dilutive options and vesting of dilutive restricted stock units | |||||||||||||||||
weighted-average mcps converted shares | |||||||||||||||||
weighted-average common shares outstanding used in diluted eps | |||||||||||||||||
basic eps | |||||||||||||||||
diluted eps | |||||||||||||||||
net cash from operating activities from continuing operations | |||||||||||||||||
proceeds from sale of product lines | |||||||||||||||||
total cash from investing activities for continuing operations | |||||||||||||||||
total cash from financing activities for continuing operations | |||||||||||||||||
(payments for) proceeds from the issuance of common stock in connection with stock-based compensation | |||||||||||||||||
proceeds from the sale of common stock, net of issuance costs | |||||||||||||||||
proceeds from the sale of preferred stock, net of issuance costs | |||||||||||||||||
net proceeds from borrowings | |||||||||||||||||
for the three-month period ended october 1, 2021: | |||||||||||||||||
balance, july 2, 2021 | |||||||||||||||||
other comprehensive income before reclassifications: | |||||||||||||||||
increase | -158,700,000 | 44,800,000 | -679,800,000 | 59,100,000 | -7,200,000 | ||||||||||||
income tax impact | |||||||||||||||||
other comprehensive income before reclassifications, net of income taxes | -158,700,000 | 44,800,000 | -679,800,000 | -670,500,000 | 59,100,000 | -7,200,000 | 288,200,000 | -129,100,000 | -256,500,000 | ||||||||
amounts reclassified from accumulated other comprehensive income | |||||||||||||||||
amounts reclassified from accumulated other comprehensive income, net of income taxes | |||||||||||||||||
net current period other comprehensive income, net of income taxes | -158,700,000 | 44,800,000 | -679,800,000 | -670,500,000 | 59,100,000 | -7,200,000 | 288,200,000 | -129,100,000 | -256,500,000 | ||||||||
balance, october 1, 2021 | |||||||||||||||||
for the three-month period ended october 2, 2020: | |||||||||||||||||
balance, july 3, 2020 | |||||||||||||||||
balance, october 2, 2020 | |||||||||||||||||
proceeds from sale of investment | |||||||||||||||||
for the three-month period ended july 2, 2021: | |||||||||||||||||
balance, april 2, 2021 | |||||||||||||||||
for the three-month period ended july 3, 2020: | |||||||||||||||||
balance, april 3, 2020 | |||||||||||||||||
pretax gain on sale of product lines and unrealized investment (gains) losses | |||||||||||||||||
total cash from operating activities from continuing operations | |||||||||||||||||
total cash from operating activities from discontinued operations | |||||||||||||||||
for the three-month period ended april 2, 2021: | |||||||||||||||||
balance, december 31, 2020 | |||||||||||||||||
for the three-month period ended april 3, 2020: | |||||||||||||||||
balance, december 31, 2019 | |||||||||||||||||
pretax gain on sale of product lines | |||||||||||||||||
proceeds from the public offering of common stock, net of issuance costs | |||||||||||||||||
proceeds from the public offering of preferred stock, net of issuance costs | |||||||||||||||||
net proceeds from the sale of envista holdings corporation common stock, net of issuance costs | |||||||||||||||||
total financing cash from continuing operations | |||||||||||||||||
cash distributions to envista holdings corporation | |||||||||||||||||
shares redeemed through the split-off of envista holdings corporation | |||||||||||||||||
category | |||||||||||||||||
buildings | |||||||||||||||||
leased assets and leasehold improvements | |||||||||||||||||
machinery and equipment | |||||||||||||||||
customer-leased instruments | |||||||||||||||||
amortization of inventory step-up | |||||||||||||||||
net operating cash from operating activities | |||||||||||||||||
net operating cash from investing activities | |||||||||||||||||
proceeds from the sale of envista holdings corporation common stock, net of issuance costs | |||||||||||||||||
net operating cash from financing activities | |||||||||||||||||
for the three-month period ended september 27, 2019: | |||||||||||||||||
balance, june 28, 2019 | |||||||||||||||||
balance, september 27, 2019 | |||||||||||||||||
less: accumulated other comprehensive income attributable to noncontrolling interest | |||||||||||||||||
accumulated other comprehensive income attributable to controlling interest | |||||||||||||||||
amortization | 320,200,000 | 216,000,000 | 108,900,000 | 285,700,000 | 187,500,000 | 92,500,000 | 271,300,000 | 179,400,000 | 89,300,000 | 90,053,000 | 86,926,000 | 83,729,000 | 81,292,000 | 82,488,000 | 83,113,000 | 63,093,000 | 55,580,000 |
for the three-month period ended june 28, 2019: | |||||||||||||||||
balance, march 29, 2019 | |||||||||||||||||
for the three-month period ended march 29, 2019: | |||||||||||||||||
balance, december 31, 2018 | |||||||||||||||||
restructuring and impairment charges | |||||||||||||||||
pretax gain on sales of investments | |||||||||||||||||
payment for purchase of noncontrolling interest | |||||||||||||||||
proceeds from sale of investments | |||||||||||||||||
less: accumulated other comprehensive income attributable to noncontrolling interests | |||||||||||||||||
accumulated other comprehensive income attributable to controlling interests | |||||||||||||||||
for the three-month period ended september 28, 2018: | |||||||||||||||||
balance, june 29, 2018 | |||||||||||||||||
decrease | -670,500,000 | ||||||||||||||||
balance, september 28, 2018 | |||||||||||||||||
for the three-month period ended june 29, 2018: | |||||||||||||||||
balance, march 30, 2018 | |||||||||||||||||
cash income tax (refunds) payments | |||||||||||||||||
for the three-month period ended march 30, 2018: | |||||||||||||||||
balance, december 31, 2017 | |||||||||||||||||
adoption of accounting standards | |||||||||||||||||
balance, january 1, 2018 | |||||||||||||||||
net operating cash from continuing operations | |||||||||||||||||
proceeds from the issuance of common stock | 131,500,000 | 61,600,000 | 75,000,000 | 60,900,000 | 30,000,000 | 148,700,000 | 110,000,000 | 54,300,000 | 68,734,000 | 38,963,000 | 33,260,000 | 71,043,000 | |||||
payment for purchase of noncontrolling interests | |||||||||||||||||
for the three-month period ended september 29, 2017: | |||||||||||||||||
balance, june 30, 2017 | |||||||||||||||||
balance, september 29, 2017 | |||||||||||||||||
for the three-month period ended june 30, 2017: | |||||||||||||||||
balance, march 31, 2017 | |||||||||||||||||
for the three-month period ended march 31, 2017: | |||||||||||||||||
balance, december 31, 2016 | |||||||||||||||||
pretax gain on sale of investments | |||||||||||||||||
cash distributions to fortive | |||||||||||||||||
distribution of noncash net assets to fortive corporation | |||||||||||||||||
total investing cash from (provided by) continuing operations | |||||||||||||||||
(a) this accumulated other comprehensive income component is included in the computation of net periodic pension cost. refer to note 7 for additional details. | |||||||||||||||||
shares redeemed through the distribution of the communications business | 2,291,700,000 | ||||||||||||||||
for the three month period ended september 30, 2016: | |||||||||||||||||
balance, july 1, 2016 | |||||||||||||||||
distribution of fortive corporation | |||||||||||||||||
balance, september 30, 2016 | |||||||||||||||||
(b) this accumulated other comprehensive income component included an income tax impact of 21 million. | |||||||||||||||||
less: income from discontinued operations, net of income taxes | |||||||||||||||||
for the three month period ended july 1, 2016: | |||||||||||||||||
balance, april 1, 2016 | |||||||||||||||||
for the three month period ended april 1, 2016: | |||||||||||||||||
balance, december 31, 2015 | |||||||||||||||||
(a) this accumulated other comprehensive income component is included in the computation of net periodic pension cost. refer to note 7 for additional details.(b) included in other income in the accompanying consolidated condensed statement of earnings. refer to note 10 for additional details. | |||||||||||||||||
net earnings from continued operations | 1,863,500,000 | 523,428,000 | 449,646,000 | 420,246,000 | |||||||||||||
non-cash items: | |||||||||||||||||
pre-tax gain on sales of investments and product line | -12,400,000 | ||||||||||||||||
total operating cash flows from continuing operations | 2,507,300,000 | 737,241,000 | 722,803,000 | 433,910,000 | |||||||||||||
total operating cash flows from discontinued operations | 62,900,000 | -60,154,000 | 2,573,000 | ||||||||||||||
proceeds from sales of investments and product line | 43,000,000 | ||||||||||||||||
proceeds from issuance of common stock | 198,100,000 | 52,279,000 | 9,950,000 | 999,842,000 | 50,480,000 | ||||||||||||
for the three months ended october 2, 2015: | |||||||||||||||||
balance, july 3, 2015 | -1,456,800,000 | -1,456,800,000 | |||||||||||||||
balance, october 2, 2015 | -1,615,500,000 | ||||||||||||||||
this accumulated other comprehensive income component is included in the computation of net periodic pension cost (refer to note 7 for additional details). included in other income in the accompanying consolidated condensed statement of earnings. refer to note 10 for additional details. | |||||||||||||||||
pre-tax gain on sales of investments | -23,500,000 | -19,200,000 | |||||||||||||||
for the three months ended july 3, 2015: | |||||||||||||||||
balance, april 3, 2015 | -1,501,600,000 | -1,501,600,000 | |||||||||||||||
this accumulated other comprehensive income component is included in the computation of net periodic pension cost (refer to note 7 for additional details). | |||||||||||||||||
for the three months ended april 3, 2015: | |||||||||||||||||
balance, december 31, 2014 | -821,800,000 | ||||||||||||||||
less earnings from discontinued operations, net of income taxes | |||||||||||||||||
earnings from unconsolidated joint venture, net of cash dividends received | 66,600,000 | 66,600,000 | 66,600,000 | 6,086,000 | -6,036,000 | -16,105,000 | -9,345,000 | 5,646,000 | -7,473,000 | ||||||||
pre-tax gain on sales of investments and a product line | |||||||||||||||||
proceeds from sales of investments and a product line | |||||||||||||||||
proceeds from sale of discontinued operations | 0 | 0 | |||||||||||||||
purchase of stock | |||||||||||||||||
dividends received related to earnings of unconsolidated joint venture | |||||||||||||||||
pre-tax gain on divestiture of a business | -33,900,000 | ||||||||||||||||
proceeds from divestiture of a business | 86,700,000 | ||||||||||||||||
for the three months ended september 26, 2014: | |||||||||||||||||
balance, june 27, 2014 | 465,100,000 | 465,100,000 | |||||||||||||||
income tax benefit | |||||||||||||||||
balance, september 26, 2014 | -205,400,000 | ||||||||||||||||
this accumulated other comprehensive income component is included in the computation of net periodic pension cost (refer to note 6 for additional details). | |||||||||||||||||
included in other income in the accompanying consolidated condensed statement of earnings (refer to note 9 for additional details). | |||||||||||||||||
for the three months ended june 27, 2014: | |||||||||||||||||
balance, march 28, 2014 | 406,000,000 | 406,000,000 | |||||||||||||||
income tax expense | |||||||||||||||||
pre-tax gain on sale of unconsolidated joint venture | -229,800,000 | -229,800,000 | -229,800,000 | ||||||||||||||
proceeds from sale of unconsolidated joint venture | 692,000,000 | 692,000,000 | 692,000,000 | ||||||||||||||
for the three months ended march 28, 2014: | |||||||||||||||||
balance, december 31, 2013 | 413,200,000 | ||||||||||||||||
pre-tax gain on sale of marketable equity securities | |||||||||||||||||
proceeds from sale of marketable equity securities | |||||||||||||||||
stock compensation expense | 85,700,000 | 56,100,000 | 27,800,000 | 30,481,000 | 29,007,000 | 26,731,000 | 23,681,000 | 23,987,000 | 25,650,000 | 23,190,000 | 22,776,000 | ||||||
for the three months ended september 27, 2013: | |||||||||||||||||
balance, june 28, 2013 | 89,700,000 | 89,700,000 | |||||||||||||||
pre-tax income | 288,200,000 | -129,100,000 | -256,500,000 | ||||||||||||||
balance, september 27, 2013 | 377,900,000 | ||||||||||||||||
this accumulated other comprehensive income component is included in the computation of net periodic pension cost (refer to note 8 for additional details). | |||||||||||||||||
for the three months ended june 28, 2013: | |||||||||||||||||
balance, march 29, 2013 | 218,800,000 | 218,800,000 | |||||||||||||||
for the three months ended march 29, 2013: | |||||||||||||||||
balance, december 31, 2012 | 475,300,000 | ||||||||||||||||
pre-tax gain on contribution of businesses to joint venture | |||||||||||||||||
proceeds from disposals of property, plant and equipment and other assets | 6,775,000 | 9,091,000 | |||||||||||||||
proceeds from contribution of businesses to joint venture | |||||||||||||||||
purchase of treasury stock | -389,920,000 | ||||||||||||||||
proceeds from the sale of discontinued operations | 0 | 0 | 337,470,000 | ||||||||||||||
proceeds of borrowings | -1,000 | 0 | |||||||||||||||
for the three months ended september 28, 2012: | |||||||||||||||||
before income tax amount | 449,600 | ||||||||||||||||
net of income tax amount | 449,600 | ||||||||||||||||
for the three months ended september 30, 2011: | |||||||||||||||||
for the nine months ended september 28, 2012: | |||||||||||||||||
for the nine months ended september 30, 2011: | |||||||||||||||||
for the three months ended june 29, 2012: | |||||||||||||||||
for the three months ended july 1, 2011: | |||||||||||||||||
for the six months ended june 29, 2012: | |||||||||||||||||
for the six months ended july 1, 2011: | |||||||||||||||||
proceeds from disposals of property, plant and equipment | 2,833,000 | -1,640,000 | 6,854,000 | 1,021,000 | 2,410,000 | ||||||||||||
for the three months ended march 30, 2012: | |||||||||||||||||
before-tax amount | 156,000 | ||||||||||||||||
tax expense | |||||||||||||||||
net-of-tax amount | 156,000 | ||||||||||||||||
for the three months ended april 1, 2011: | |||||||||||||||||
consideration received in shares | |||||||||||||||||
proceeds from contribution of businesses to joint venture and other | |||||||||||||||||
cash paid for other investments | |||||||||||||||||
proceeds from divestitures | |||||||||||||||||
net proceeds | -562,049,000 | 17,271,000 | |||||||||||||||
balance, january 1, 2009 | |||||||||||||||||
net earnings for the year | |||||||||||||||||
dividends declared | |||||||||||||||||
common stock based award activity | |||||||||||||||||
unrealized gain on available-for-sale securities | |||||||||||||||||
unrecognized pension and postretirement plan benefits | |||||||||||||||||
increase from translation of foreign financial statements | |||||||||||||||||
balance, december 31, 2009 | |||||||||||||||||
stock dividend | |||||||||||||||||
common stock issued in connection with lyons’ conversions | |||||||||||||||||
unrecognized pension and postretirement plan costs | |||||||||||||||||
non-controlling interest acquired | |||||||||||||||||
balance, december 31, 2010 | |||||||||||||||||
common stock issuance | |||||||||||||||||
decrease from translation of foreign financial statements | |||||||||||||||||
change in non-controlling interests | |||||||||||||||||
balance, december 31, 2011 | |||||||||||||||||
less: earnings from discontinued operations, net of tax | 0 | 199,118,000 | 9,112,000 | ||||||||||||||
total operating cash flows (used in) from discontinued operations | |||||||||||||||||
net cash flows from operating activities | 699,942,000 | 662,649,000 | 436,483,000 | ||||||||||||||
total investing cash flows used in continuing operations | |||||||||||||||||
investing cash flows used in discontinued operations | |||||||||||||||||
change in foreign currency translation adjustment | -603,600 | -140,300 | 253,000 | ||||||||||||||
change in unrealized gain on available-for-sale securities, net of income taxes | |||||||||||||||||
comprehensive income | -809,100 | 89,000 | 690,800 | ||||||||||||||
change in accounts payable | 9,284,000 | 27,374,000 | |||||||||||||||
total investing cash flows from continuing operations | -5,597,508,000 | -563,434,000 | |||||||||||||||
investing cash flows from discontinued operations | |||||||||||||||||
net proceeds of borrowings | |||||||||||||||||
change in unrealized gain on available-for-sale securities, net of income tax | |||||||||||||||||
earnings from unconsolidated joint venture | -14,475,000 | ||||||||||||||||
total investing cash flows from discontinued operations | -1,521,000 | ||||||||||||||||
unrealized gain on available-for-sale securities, net of income tax | 8,400 | ||||||||||||||||
proceeds from divestitures and refundable escrowed purchase price | |||||||||||||||||
balance, january 1, 2008 | |||||||||||||||||
cumulative impact of change in measurement date for post - employment benefit obligations, net of taxes | |||||||||||||||||
treasury stock purchase | |||||||||||||||||
balance, december 31, 2008 |
We provide you with 20 years of cash flow statements for Danaher stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Danaher stock. Explore the full financial landscape of Danaher stock with our expertly curated income statements.
The information provided in this report about Danaher stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.